Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells

por Aretz, Philippe, Maciaczyk, Donata, Yusuf, Suad, Sorg, Rüdiger V., Hänggi, Daniel, Liu, Hongjia, Liu, Hongde, Dakal, Tikam Chand, Sharma, Amit, Bethanabatla, Ramakrishna, Neumann, Silke, Maciaczyk, Jarek
Publicado 2022

Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro

por Suwala, Abigail Kora, Koch, Katharina, Rios, Dayana Herrera, Aretz, Philippe, Uhlmann, Constanze, Ogorek, Isabella, Felsberg, Jörg, Reifenberger, Guido, Köhrer, Karl, Deenen, René, Steiger, Hans-Jakob, Kahlert, Ulf D., Maciaczyk, Jaroslaw
Publicado 2018

WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells

por Yusuf, Suad, Aretz, Philippe, Nickel, Ann-Christin, Westhoff, Philipp, Sharma, Amit, Qin, Nan, Remke, Marc, Steiger, Hans-Jakob, Hänggi, Daniel, Liu, Hongjia, Liu, Hongde, Neumann, Silke, Reifenberger, Guido, Maciaczyk, Jarek
Publicado 2022

A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma

por Herrera-Rios, Dayana, Li, Guanzhang, Khan, Dilaware, Tsiampali, Julia, Nickel, Ann-Christin, Aretz, Philippe, Hewera, Michael, Suwala, Abiagail Kora, Jiang, Tao, Steiger, Hans-Jakob, Kamp, Marcel Alexander, Muhammad, Sajjad, Hänggi, Daniel, Maciaczyk, Jarek, Zhang, Wei, Kahlert, Ulf Dietrich
Publicado 2020